Results 201 to 210 of about 141,118 (333)
Abstract Introduction Low‐value care refers to health services for which the potential harms or costs outweigh the benefits of use. Bronchiolitis is the most common and among the most costly causes of pediatric hospitalizations. Evidence consistently shows that many common tests and treatments used to manage bronchiolitis do not improve outcomes ...
Branden Bonham +39 more
wiley +1 more source
Tenofovir alafenamide fumarate use for HIV pre-exposure prophylaxis and weight gain. [PDF]
Shi F, Xia H, Weissman S, Li X, Yang X.
europepmc +1 more source
Abstract The isoproterenol‐induced myocardial infarction model is a well‐established experimental approach for studying cardiac injury and testing potential protective treatments. By overstimulating beta‐adrenergic receptors, this model closely reproduces key features of human heart attacks, including oxidative damage, calcium imbalance, inflammatory ...
Bushra Imran +5 more
wiley +1 more source
Preference heterogeneity for HIV pre-exposure prophylaxis care among gay, bisexual, and other men who have sex with men in the United States: a large discrete choice experiment [PDF]
Viraj V. Patel +10 more
openalex +1 more source
Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network [PDF]
Matthew A. Spinelli +6 more
openalex +1 more source
Relationships between periodontitis, tooth loss, and metabolic syndrome indicators
Abstract Background This study investigates how poor oral health impacts metabolic alterations, specifically evaluating the effects of periodontitis and tooth loss, either individually or in combination, on the number of metabolic syndrome (MetS) indicators.
Verbênia Silva Conceição +14 more
wiley +1 more source
Abstract Background Fibroblast growth factor‐2 (FGF‐2) is a novel agent utilized in periodontal regeneration therapy. However, its clinical efficacy compared with autologous bone graft (ABG), a long‐established treatment, remains unclear. This study aimed to compare the clinical outcomes of FGF‐2 and ABG and to assess the impact of patient background ...
Toshiki Matsumoto +11 more
wiley +1 more source
Changes in geographic drive time access to pre-exposure prophylaxis (PrEP) in the United States, 2017 to 2025. [PDF]
Mancuso N +3 more
europepmc +1 more source

